Letter in Response to “Lomitapide: A Medication Use Evaluation and a Formulary Perspective” by Esba and Alharbi

• Dirk J. Blom

Affiliations

Dirk J. Blom

ORCiD

1 Department of Medicine and Cape Heart Institute, University of Cape Town, Cape Town, South Africa